WO2003075978A2 - Clinical syringe with electrical stimulation aspects - Google Patents
Clinical syringe with electrical stimulation aspects Download PDFInfo
- Publication number
- WO2003075978A2 WO2003075978A2 PCT/US2003/006852 US0306852W WO03075978A2 WO 2003075978 A2 WO2003075978 A2 WO 2003075978A2 US 0306852 W US0306852 W US 0306852W WO 03075978 A2 WO03075978 A2 WO 03075978A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cannula
- tissue
- electrode
- electrical
- electrodes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
- A61M5/422—Desensitising skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
- A61M5/3291—Shafts with additional lateral openings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3295—Multiple needle devices, e.g. a plurality of needles arranged coaxially or in parallel
- A61M5/3298—Needles arranged in parallel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
- A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
Definitions
- the invention concerns a syringe apparatus for subsurface injection of compositions into biological tissues, together with simultaneous or post-injection application of an electric field to the site of the injection.
- liquid medicinal compositions are injected into the muscular tissue of humans or animals using the apparatus, and the effects of the injection are modified (preferably optimized or amplified) by action of the electric field on either or both of the molecules of the composition and the tissue cells at the site of the injection.
- the syringe apparatus is disclosed in embodiments suitable for day-to-day clinical use for injection and electrical stimulation of tissues.
- the apparatus is useful to facilitate infusion of injected pharmaceutical compositions into cells, for example to obtain or enhance an immunological reaction to the composition or its by-products.
- Iontophoresis and electrophoresis generally concern applying a direct current electric field in order to drive migration of positive and negative ions by electrostatic attraction and repulsion toward and away from an anode and cathode. Electric fields also tend to increase the mobility of the ions generally. Iontophoresis typically involves causing polar ions in a solution to migrate through an intact membrane such as the skin. Electrophoresis concerns the migration of ions in a fluid or gel under the influence of a polar electric field (i.e., a field with at least a direct current component). [0006] Electroporation often involves a relatively higher power electric field, often applied briefly or pulsed.
- a field applied at sufficient amplitude and/or for a sufficient duration can induce microscopic pores to form in a membrane.
- the pores are commonly called “electropores” and the process of forming them is called electroporation.
- the pores may be larger or smaller and may persist for a longer or shorter time.
- the pores persist temporarily, such as only during application of the field, and close or heal quickly. It is possible to damage tissue permanently by application of electromagnetic energy of too high a power level. Such damage might be caused by application of too high an energy level to a large volume of tissue such as a limb or other anatomical structure.
- electrical stimulation is not limited to any one or any particular combination of iontophoresis, electroporation, electrophoresis or any other electrical effects.
- the term as used herein is intended to encompass any such effects.
- a given electrical stimulation could have results that fall into more than one class, or possibly could be stronger in one or another due to the amplitude, polarity, spatial geometry and/or timing involved.
- a given direct current or low frequency field could conceivably have sufficient amplitude to induce pore formation (electroporation) while also causing electrostatically driven ion migration through a membrane (iontophoresis) and accumulated migration with time (electrophoresis).
- electroporation involves higher electric field amplitudes than the other effects, and typically application at such amplitudes is brief or intermittent or is pulsed at a duty cycle that is sufficiently low to prevent unacceptable tissue damage.
- the application of an electromagnetic field to tissue is complicated by the fact that tissue is not homogeneous, isotropic or otherwise regular from an electromagnetic perspective.
- An applied field and an induced current can become concentrated by variations in the material properties of the tissue, including but not limited to the magnetic permeability and resistivity of tissues on a microscopic scale, and on a more macroscopic scale, by the anatomical structure and organization of tissue
- One such effect is the production of antibodies and potentially the stimulation of systemic production of such antibodies, as a means to induce or improve immunological attack on adverse pathologies such as viruses, cancer, antibiotic resistant bacteria, parasitic infections and other pathologies.
- Another such effect is to induce a strong antigen-specific cellular immune response.
- Patents 5,810,762; 5,704,908; 5,702,359; 5,676,646, 5,545,130; 5,507,724; 5,501 ,662; 5,439,440; and 5,273,525, disclose electroporation or electrical stimulation methods and apparatus that suggest useful electrical field strengths range from about 200 V/cm to about 20KV/cm.
- U.S. Patents 5,968,006 and 5,869,326 suggest electric field strengths as low as 100 V/cm for certain in vivo electrical stimulation procedures. These disclosures cover orders of magnitude in the intensity of the proposed voltage gradient. It is well known from the literature that the electrical properties of tissue are substantially resistive. Under Ohm's law, current dissipation is equal to voltage divided by resistance. Power dissipation or joule heating is proportional to the product of the voltage and current. Therefore, according to the disclosures and the wide ranges of proposed voltages, at least tissue heating, and possibly also other effects will vary substantially as well.
- a prospective patient may well hesitate if offered a therapy that involves attaching his or her person to a device that is coupled to the domestic electric power mains.
- a therapy that involves attaching his or her person to a device that is coupled to the domestic electric power mains.
- safety precautions are essential and some design features are required by law.
- Precautions may include thickly insulated wires, grounding wires, high voltage insulation on leads and electrodes and the like. The appearance of such structures can aggravate a subject's fears.
- Electrodes intended to apply electromagnetic energy in conjunction with infusion of a substance by local or systemic injection, are shown in US Patents 5,439,440; 5,702,359; 6,009,347; and 6,014,584, all to Hofmann.
- US Patents 5,873,849 - Bernard and 6,041 ,252 - Walker et al. include disclosures of field patterns versus injection parameters, and discuss particular arrays of electrodes, for example in equilateral trios of anode/cathode arrangements in regular repetitive patterns of adjacent sets of electrodes that together encompass an extended area of tissue.
- Such an array of electrodes and associated electrical leads is rather spectacular.
- pulses are applied in a kilovolt voltage range using facilities that apply the voltage to the subject while protecting the technician from contact.
- the electrodes, leads, insulation and the like result in an electrical apparatus that is quite daunting in appearance.
- Patent 5,439,440 for example, teaches alternative contactors.
- a plier-like electrically insulated tool has paired-contactors that are mechanically arranged so as to compress or pinch a loose portion of flesh.
- an array of ten needles forms the electrode structure of two spaced rows of five needles commonly. The two rows of five are coupled to the anode and cathode of a driving circuit, respectively.
- the '359 patent additionally discloses a circular array wherein needle-shaped contactors are connected by well-insulated connectors to a drive apparatus that resembles the ignition coil and distributor of an automobile engine.
- the '347 patent has a seven-by-seven position array of needle electrode positions. Each needle is mounted slidably in a contacting pad such that the advance of the needle can be controlled.
- the patent teaches positioning each needle in the array at a selected depth, for example with the distal ends or points of the needles being placed just inside the far boundary of a gland or other organ to be treated, and thereby placing a maximum length of each electrode in the tissue of the organ.
- US Patent 5,674,267 - Mir et al. teaches a similar arrangement comprising an array of needles. At least three are apparently used, but any number can be provided with each individual needle being paired with another needle. The device sequentially applies a driving voltage to each pair.
- the contactors of the foregoing patents which are hereby incorporated for their teachings of electrical arrangements and therapeutic methods, show that it is possible to place a number of electrodes into a volume of tissue so as to disperse the positions at which one or both terminals of an electrical circuit are coupled to the tissue.
- the arrays of multiple needles may be reasonably frightening to the patient, particularly when combined protective design features that appear aimed at preventing inadvertent electrical shock. Such contactors are most useful in a situation in which the patient is not conscious or otherwise cannot see the needle array and electrical driving apparatus.
- the invention is intended to provide a clinically optimal and practical device for simultaneously or sequentially effecting an injection and applying electromagnetic energy at the site of the injection.
- injection and electrode structures are provided together.
- the injection aspects are arranged to be practical for the clinician and the electrical aspects are made tolerable for the patient or subject.
- the injection structure preferably comprises certain elements that are substantially conventional, including a cannula for piercing the tissue, coupled to a collapsible volume for containing a liquid substance. Using additional electrodes and/or using at least part of the cannula and its carrying structure as an electrode and/or with a tissue surface contact electrode, an electromagnetic field is applied.
- passive (manually operable) and/or active (automatic) movable portions are provided for protectively sheathing potentially injurious portions of the apparatus such as portions that contact tissues and/or have sharp points, for example deploying a protective cover, or operating to retract a dangerous structure.
- the applied electric field is arranged to encompass substantially the same volume of tissue where the liquid substance is injected.
- the technician injects the substance and applies the field while the substance is present in the area.
- the field can be activated and the injection made in either order, provided that the field and the resulting electrical stimulation occur while the substance is infused in the area of interest.
- automatic triggering and timing are employed to activate the electric field simultaneously with injection or for a period commencing after injection, and may also be used for automatic sheathing or automatic retraction of the cannula and/or electrodes.
- the invention is practical and convenient. No expert skills are needed to arrange a field that will intersect the site of an injection, and to appropriately time the injection versus application of the field. Nevertheless, the arrangement is versatile in that it can be used with various treatment substances and to obtain various electrical field properties with respect to current, voltage and timing.
- the injector comprises a plunger and a sensor detects passage of a portion of the plunger so as to trigger the application of electrical energy simultaneously with passage or at predetermined later time or for a predetermined time interval.
- the composition can diffuse through pores that are opened by the electrical energy or can involve other methods or effects of electrical stimulation.
- An injector such as a syringe has a reservoir for the treatment composition and injection cannula.
- the cannula can function as an electrode, and one or more additional electrodes are provided as opposed electrodes.
- the electrodes can each have tissue penetrating needles, or one or more electrodes can have a surface bearing conductive contact part.
- the syringe or other injector and a drive unit that applies electrical power to the electrodes are operable in a sequence, and can be triggered by switches or automatically upon detection of the injection proceeding to a predetermined state.
- the treatment device preferably uses a disposable syringe received in a carrier and generally is provided with a non-threatening appearance by minimizing tissue penetration and potential high voltage aspects.
- a preferred embodiment is robust and comprises electrically reusable parts that are coupleable to the injector.
- the patient contact portions and the substance reservoir are disposable and inexpensive.
- the injector is meek in appearance, preferably minimizing the appearance of arrangements such as arrays of needle-like electrodes and injectors as well as aspects that suggest a painful or dangerous form of electrical energy.
- BRIEF DESCRIPTION OF THE DRAWINGS [0032] There are shown in the drawings certain examples and embodiments of the invention as presently preferred, which are intended to illustrate aspects of the invention and not to limit the invention to the specific examples shown. Throughout the drawings, the same reference numbers identify corresponding or functionally equivalent parts.
- Fig. 1 is a schematic illustration showing a clinical syringe device with electrical stimulation capabilities according to the invention, as deployed to treat tissue shown in section.
- Fig. 2 is a detailed section view showing a treatment site and illustrating certain aspects of an alternative embodiment.
- Fig. 3 is a corresponding section view showing an alternative embodiment with an associated triggering sensor.
- FIGs. 4 and 5 are partial perspective views of the invention with alternative electrode arrangements.
- Fig. 6 is a perspective view showing an embodiment comprising a carrier for receiving a disposable syringe or the like, and having multiple penetrating electrodes and mechanical contacts to make electrical connections.
- Fig. 7 is a perspective view showing a combined cannula and electrode structure for use with a syringe barrel (not shown).
- Fig. 8 is a perspective view showing a carrier for a syringe, with an alternative electrode assembly and a triggering sensor.
- Fig. 9 is a perspective view showing an alternative penetrating electrode structure.
- Fig. 10 is a perspective view of an alternative embodiment having a carrier with a spring biased electrode.
- Fig. 11 is a perspective view showing an alternative embodiment and alternative resiliently biased electrode.
- Fig. 12 is a perspective view for illustrating certain aspects of the respective embodiments.
- Fig. 13 is a perspective view of an alternative embodiment similar to that of Fig. 5, shown partly in section.
- Fig. 14 is a perspective view of another alternative embodiment, shown partly in section.
- Fig. 15 is a section view along line 15-15 in Fig. 13.
- Fig. 16 is a combined view showing a 1 :1 electrode arrangement, or a removable-cannula 1 :1 :1 electrode:cannula:electrode arrangement, together with a table showing several possible polarity combinations therefor.
- Fig. 17 is a plan view showing an alternative trilateral pattern of three electrodes and an optionally centered cannula.
- Fig. 18 is a plan view showing an alternative quadrilateral or quincunx pattern of four electrodes with the cannula in the middle.
- Fig. 19 is a schematic elevation view showing an exemplary lateral fluid emission pattern from two cannulae.
- Fig. 20 is a schematic elevation view showing an exemplary axial fluid emission pattern.
- Fig. 21 is an elevation view showing a practical embodiment using two disposable syringes in a carrier having electrical connections for using the syringe cannulae as opposed electrodes.
- Fig. 22 is an elevation view corresponding to Fig. 1 , wherein the syringes are carried on individual carriers that snap together with one another, and further wherein the syringe cannulae are diverted from a straight line configuration for adjusting the spacing between such electrodes.
- Fig. 23 is a perspective view showing an alternative embodiment wherein a carrier has an on-board solid wire electrode and electrical connections for the electrode and for making contact with a syringe cannula fittable into the carrier, this cannula also being diverted for spacing purposes.
- Fig. 24 is a perspective view of a carrier for a syringe (not shown) wherein the carrier has dual solid wire electrodes straddling a channel into which a syringe can be snap-engaged and operated.
- Fig. 25 is a perspective view of a clasp for snapping over the syringe in the carrier to lock the syringe in place and also to make electrical connections as described below.
- Fig. 26 illustrates an alternative configuration for making electrical contacts.
- Fig. 27 illustrates an insert-twist plug member for use with a configuration as in Fig. 26.
- Fig. 1 can have a hypodermic syringe 32, and in addition to the sharpened cannula 34 of the syringe, has one or more additional electrodes 36.
- These can be penetrating electrodes of similar elongated gauge and sharpness as compared to the cannula 34 or can be shallower or deeper penetrating devices or even surface contactors.
- the additional electrode(s) 36 may be separate solid elongated metal "sharps" constructed from stainless steel or other conductive material.
- the cannula 34 can form one of the electrodes and any number of additional electrodes 36 may be provided to operate in opposition to one another or in opposition to the cannula as an electrode.
- the electrical signal can be applied in any timed sequence and/or spatial pattern of application of electrical energy of any polarity, amplitude or program of pulse, frequency, or amplitude modulation, for example as disclosed in the references mentioned in the foregoing Background of the Invention, which are incorporated in this disclosure.
- the cannula of the syringe 34 is caused to pierce a biological tissue 50, such as human muscle tissue.
- a biological tissue 50 such as human muscle tissue.
- manual operation of the syringe 32 namely advance of a plunger 42 in the syringe barrel 44, discharges the contents of the barrel into the tissue 50 at a site 52 point below the tissue surface.
- an electrical signal is applied using at least two electrodes (one of which may be the cannula 34 and the other may be an additional penetrating electrode 36 as shown in Fig. 1).
- application of electromagnetic energy may be possible using electrodes that are otherwise spaced around the injection site 52, for example by an electromagnetic radiation technique.
- electromagnetic energy 55 indicated in Fig. 1 by a field represented by dash- dot lines, is applied over an area that at least partly encompasses the site 52 of the injection.
- the electromagnetic energy comprises a voltage gradient and resulting current flow that is directed toward the opposed electrode and thus part of the field may not intersect a large portion of the injection site 52. It is possible by providing electrodes that are spaced to straddle around at least part of the injection site, to cause the voltage gradient to intersect a larger part of the injection site 52, as shown in Fig. 2.
- the cannula 34 acts as one electrode or conducting pole of a pair 34, 36 carrying an electrical stimulation signal.
- Two electrodes 36 apart from the cannula 34 are shown in Fig. 2, etc.
- two or more needles are parallel to and equidistant from a cannula 34, acting as opposed conductors or poles for the electrical signal, either together with one another or with the cannula.
- Both the cannula 34 and the sharpened penetrating electrodes 36 in that arrangement can be referred to as needles.
- the electrodes 36 apart from the cannula 34 are replaced by one or more surface contacting electrodes (not shown in Figs. 1-3) that contact or possibly penetrate the skin or other tissue 50 less deeply, if at all, in the vicinity of the penetration of cannula 34.
- surface contacting electrodes are disclosed, for example with reference to Figs. 4, 5 and 8, comprising a range of materials and structures such as conducting sheet material (e.g., metal mesh, carbon coated or carbon containing polymer adhesive film electrode), resiliently biased contactors and the like.
- a cannula 34 and one or more electrodes 36 are provided in a form apt for use with a disposable plastic syringe barrel.
- the cannula 34 can be commonly mounted with penetrating electrodes 36 on a plastic molded component 62, for example attachable to a disposable syringe barrel 44 using a standard Luer-lock fitting 64 as shown in Figs. 6 and 7 or by other means (e.g., Fig. 9).
- a complete disposable syringe having a barrel 44, plunger 42 and cannula 34 can be received in a carrier 66 as in Figs. 8 and 10-12.
- Electrodes can be provided on the electrode carrying component 62 or the carrier 66, or molded into their structures.
- resilient conductive contacts can be appropriately placed for making electrical contact with penetrating needles (possibly including the cannula) or for making contact with exposed metal or conductive parts so as to couple the driving signal to electrodes that are in turn coupled to the tissue at and/or adjacent to the site 52 of the injection.
- the electrodes employed are typically coupled to the anode and cathode of the drive circuit using conductors (i.e., wires). It will be appreciated that it is also possible to induce a current in a conductive electrode by a current induction technique. In that case an electrode or a conductor coupled to the electrode is irradiated with an alternating current electromagnetic signal to induce a current in the electrode, and the induced current produces the electrical stimulation effects sought.
- Facilities such as electrical contacts, terminals, plug receptacles and the like preferably are spaced or similarly isolated from the insertable or penetrating or tissue-contacting portions of the electrodes and cannula(e), preferably by structuring the electrode carrying member 62 (preferably including the cannula 34) so as to separate and/or place a barrier between sterile tissue-contact and non-sterile electrical-contact portions.
- the electrical connections can be completed without compromising the sterility of the needles prior to injection, and the carrier can be used safely for successive treatments without the need to completely sterilize the carrier with each use.
- the needle assembly preferably comprises or is associated with a protective cover such as a displaceable needle sheath (not shown) that covers the injectable or fluid-contact portions of the needles (cannula and electrode(s)) before and after injection and treatment.
- a protective cover such as a displaceable needle sheath (not shown) that covers the injectable or fluid-contact portions of the needles (cannula and electrode(s)) before and after injection and treatment.
- the entire needle assembly and assembled sheath can be individually sterile packaged, and optionally preloaded with the composition to be injected.
- the electrical connections area 68 for example as shown in Fig.
- tissue engaging or penetrating structures 34, 36 can be isolated from one another by a suitable barrier of glass, plastic, metal or the like.
- the structure effectively forming a barrier between the tissue contact and electrical contact functional portions also serves to provide a mechanical maximum limit or stop defining the depth of penetration of the needle(s).
- the syringe/needle assembly as described above is associated with electrical and electronic components that appear to be low voltage apparatus or can be plainly battery powered. According to another aspect the penetrating components are kept to the same number as in a more conventional injection, namely one.
- the electrical driving signal can be triggered from the syringe or carrier (collectively the "treatment device").
- a pushbutton can be provided for manual actuation.
- a mechanical limit switch (not shown) can be operated by advance of the syringe plunger to a given point, or in another embodiment the advance of the syringe to a predetermined triggering point is detected optoelectrically.
- the signals developed in these and similar ways can be coupled through a separate driving unit 82 that produces the signal for applying the electrical field to the tissue site.
- the driving unit 82 also can be arranged to operate visible and/or audible indicators that determine or indicate phases of operation such as a "ready" condition, the start and/or completion of the stroke of the syringe plunger, commencement of application of the electrical drive signal, etc., completion of a treatment cycle, system short circuit or continuity fault detection warning, and so forth.
- the invention comprises a cannula 34 coupled to a source of a liquid treatment composition.
- the cannula is part of a common manually operable hypodermic syringe 32 such as a disposable plastic syringe, a glass syringe or the like, wherein the cannula 34, which is intended to pierce the tissue 50, is coupled to a barrel 44 that is collapsible or expandable by displacement of a piston or plunger 42 sealed to the inner walls of the barrel.
- At least one electrode 36 is coupled to a source 82 of an electrical signal.
- the cannula 34 is used as one of the electrodes, but it is also possible that the cannula could be electrically uncoupled or floating and that other conductors are used as electrodes.
- the cannula 34 is coupled by a spring contact lead 92 to one terminal of the driving unit 82 and a second solid needle 94 is used as an opposed electrode 36, coupled to the other terminal of the driving unit 82 by a spring clip lead, which in this instance is an alligator clip. It would also be possible to use two complete syringes (not shown), the cannulas 34 of which are coupled to the driving unit 82 as opposed electrodes.
- the source or driving unit 82 for the electrical signal is shown only generally in Fig. 1.
- a voltage source 96 is provided, which preferably comprises an on-board battery as opposed to a daunting-appearing AC wall plug cord.
- the driving unit 82 can have various arrangements for controlling the driving signal.
- the driving unit may be arranged to control the application of energy according to user input or the driving unit may be preprogrammed.
- the control can involve choice of various amplitude and timing attributes or simply the selection of available predetermined control parameter or control setpoints to be met by a feedback control arrangement.
- the voltage or current amplitude and pulse characteristics can be selectable or the user can select characteristics.
- the signals can have selectable AC and DC components.
- the voltage polarity can be reversible.
- the signals can vary with time, such as a certain number of trains of pulses with interspersed pauses.
- the controller also can vary the application of energy spatially, for example reversing orientation by changing polarities (assuming two contact points) or by changing the orientation of the electric field in other ways, such as rotating the field direction be switching the signal to different pairs of electrodes in an array of three or more.
- switching functions are illustrated schematically by a simple switch 98.
- the driving unit 82 typically comprises a power supply and one or more amplifiers or inverters that develop a voltage that is then applied by transistors or other switching elements to the electrodes.
- the driving unit 82 also can have safety features, for example to disable operation in the event of a detected short circuit, and adaptive features, such as controls operable to seek or maintain a preset parameter value (e.g., to control for a peak current setpoint), while varying other parameters (e.g., voltage) to achieve that value.
- the syringe 32 is operated to discharge through the cannula 34, and the electrodes 34, 36 are electrically driven in a sequence that results in application of electrical energy to the subsurface tissue site 52 of the injection during the time that the injected composition is present.
- the electrical signal applied to the tissue site is sufficient to effect a stimulation response in the tissue at the site, or a reaction in the composition that is infused into the tissue.
- the electrical signal could be sufficient to open pores in tissue membranes concurrently (or sequentially) with application of an injected composition.
- the composition could comprise plasmids that are to invoke immunological effects, and the pores might permit the composition to diffuse or advect more readily into the cells or into contact with structures subdivided by such membrane.
- the combination of delivery of a therapeutic composition and application of an electric field may have an associated therapeutic effect or may enhance a therapeutic effect otherwise obtainable from the composition, but at a less vigorous rate.
- the electrodes such as the cannula 34, and possibly other needles 36 used as electrodes, are electrically conductive over at least a portion of their surfaces in contact with the tissue.
- the needles can comprise an array of elongated needle structures extending substantially parallel to the cannula used for the injection. These needles are advantageously parts of a single treatment device, but can potentially be separate structures as in Fig. 1. [0079] As shown in Fig. 2, the needles (cannulas 34 or other electrodes
- the electrode or cannula can have a substantially insulating plastic coating 104, for example of Teflon (polytetrafluoroethylene) over its length, except for a portion at the distal portion at the level of the injected composition (such an embodiment is shown and discussed with respect to Figs. 13 and 15 below).
- Fig. 2 also demonstrates that the coating can be discontinuous to provide separated areas of concentrated application of electrical energy over the length of the needle (cannula or solid electrode or the like).
- the electrode provides a conductive surface in electrical contact with the tissue during penetration of the tissue by the cannula, or at least while the injected composition is present.
- Fig. 3 shows an embodiment in which the timing of the signal is specifically related to operation of the syringe to make the injection.
- the source of the treatment composition is a preferably-disposable plastic syringe 32 and the cannula 34 of the syringe functions as one of the electrodes driven by the electrical drive unit 82.
- At least one other electrode 36 is provided to make contact and the cannula and other electrode are coupled to the electrical drive unit as in Fig. 1.
- Fig. 1 shows an embodiment in which the timing of the signal is specifically related to operation of the syringe to make the injection.
- the drive unit 82 is triggered when sensing that the operation of the syringe 32 has advanced to the extent that there is expected to be a substantial concentration of the treatment composition in place at the site 52 of the injection.
- the syringe barrel is substantially light transmissive (transparent or translucent).
- a lamp, LED or similar light source is provided on one side of the syringe barrel 44 and a photodetector 114 such as a photo diode or photo transistor is coupled to the barrel on a diametrically opposite side.
- the photodetector responds to light from the light source until the plunger 42 of the syringe, which generally is opaque at least at the plunger seal end, passes between the light source 112 and the photodetector 114, producing a triggering signal that is applied to the source 82 of the electrical drive signal.
- the source 82 can have a current source, threshold detector, one shot timer, amplifier and any other combination of components (not shown) to produce a driving signal between the electrodes (in this case between the cannula and the separate electrode) triggered by operation of the syringe.
- the signal can be maintained for a given time after triggering or may persist only so long as the plunger obstructs a line of sight between the light source and the photodetector, etc.
- the electrical drive signal coupled to the cannula 34 is connected by spring clip 92 at the proximal end of the cannula adjacent to the syringe barrel 44.
- This connection point is available unless the cannula is to be inserted into the tissue to the hub at which the cannula is mounted. It is advantageous as previously discussed if the cannula is fixed to a needle assembly that has some form of sterile barrier located between the distal or injection end of the cannula 34 and an electrical contact area of the cannula, so that any concerns regarding the sterility of the electrical portions, which advantageously are intended to be reused, do not compromise the sterility of the injection.
- Figs. 4 and 5 demonstrate a contact electrode arrangement that is less intrusive than the penetrating electrode arrangements of Figs. 1-3, but is still based on the use of a conventional preferably-disposable syringe and cannula.
- the cannula 34 is electrically connected to function as one of the electrodes via a clamp or spring clip collar 122 at its proximal end.
- the opposed electrode is provided by a sheet metal spring member 132 that attaches to the body of the syringe 32 and bears resiliently against the surface of the tissue 50 when the cannula 34 is inserted into the tissue to accomplish the injection.
- the spring member 132 can have an unloaded position, shown in dashed lines, that is relatively forward in the direction of injection, and can be deflected resiliently against pressure from the surface of the tissue (not shown in Fig. 4), such that the spring member 132 bends back into the position shown in solid lines. This places the electrode formed by spring member 132 at a predetermined relative position relative to the cannula 34, achieves electrical connection with the tissue by conductive contact, and also at least roughly determines the depth of the injection.
- a similar result can be obtained by providing a spring member 132 that is resiliently pivoted, for example being canted off the longitudinal center line at rest, and mounted such that pressure against the tissue during injection brings the spring member into a predetermined position when the cannula 34 reaches a predetermined injection depth.
- Electrode contact between the tissue and the conducting parts of the arrangement shown can be facilitated by choosing the material on the surface of the electrode or its surface configuration.
- a conducting gel can be applied to improve contact.
- the surface can be smooth to increase the total surface area in contact or can be rough to increase the intimacy of electrical connection at discrete points on the surface.
- the surface electrode need not be limited to surface contact and can have penetrating structures such as relatively short point contacts which compress and may pierce the tissue to a depth of up to a millimeter or so.
- the electric field in the tissue has a voltage gradient between the cannula and the spring member surrounding the cannula at the surface of the tissue, which is largely in a radial direction parallel to the tissue surface.
- the effectiveness of this arrangement for electrical stimulation may vary substantially with the depth of the injections or injections. Specifically, a deeper injection site may not be in optimal position to be subjected to a substantially radial voltage gradient at the surface, as compared to a shallower injection.
- Insulating a length of the cannula provides an axial component to the voltage gradient and improves the extent to which the injection site is exposed to the electrical stimulation field.
- Fig. 5 shows a related embodiment.
- a surface electrode coupled to the drive unit 82 is not mounted mechanically on the syringe and does not bear against the tissue with resilient pressure as in Fig. 4.
- the surface contact comprises a flexible conductive sheet 136 with an opening 138.
- the injection is made through the opening 138 after attaching the sheet to the tissue.
- the sheet 138 can comprise a conductive mesh, a conductive plastic wherein carbon or other conductive particulate material is provided on the surface or throughout the material, a metal foil, etc.
- the sheet can be attached adhesively or using a conductive gel.
- a conductive gel As in the embodiment of Fig.
- this arrangement is most effective with shallow injections or with deeper injections made using an opposed electrode, such as the cannula 34, which is insulated along its proximal length.
- an opposed electrode such as the cannula 34
- the cannula 34 discharges axially at its sharp end. It will be appreciated that the cannula 34 can be made to discharge laterally by providing a lateral opening or openings at a space from the distal end, which distal end also may be blocked. This method permits a portion of the cannula 34 to extend above and below the site of the injection. Such an embodiment is discussed below with reference to Fig. 19.
- Figs. 6-12 demonstrate several exemplary practical arrangements for the treatment device of the invention. These arrangements preferably are based in part on a standard syringe barrel 44 and plunger 42, but also are applicable to less standard injection apparatus.
- the device can be used with a disposable syringe having a standard cannula 34.
- Fig. 6 demonstrates an embodiment in which the syringe barrel 44 is coupled to a delivery assembly 142, also shown in Fig. 7, comprising a central cannula 34 and a pair of needle electrodes 36 in a single unit.
- a delivery assembly 142 also shown in Fig. 7, comprising a central cannula 34 and a pair of needle electrodes 36 in a single unit.
- the drive unit 82 containing the electrical power supply and switching device operable to develop an electrical signal is not shown in these figures (see Figs. 1-3).
- the device comprises an injector 32 whereby a reservoir for holding a treatment composition is coupled to an injection cannula 34 and has at least one electrode 34, 36, 132, etc., to be coupled to a drive unit 82.
- the injector and the drive unit are operable in a sequence as above, to apply the treatment composition to a subsurface site 52 in the tissue 50 by injection and to apply the electrical signal to the tissue site for affecting a reaction at the site to the treatment composition.
- Figs. 6 and 7 demonstrate an embodiment in which three needles are mounted on a block or assembly 142 such that the needles are exposed at the distal side of the block, and the block forms a barrier between that area and more proximal contact points at which openings 148 electrical contact can be made with the needles, or at least with conductors 68 that are electrically coupled to the needles.
- the assembly block 142 can define openings 148 at which short lengths of the needles are accessible to be engaged with a spring clip or alligator clip.
- electrical contact screws, contact plug/receptacle arrangements or the like can be provided.
- the conductors which electrically engage with the electrodes or needles are provided in the form of plugs and mating receptacles.
- the electrical contact area is well clear of the portion of the needles that is to penetrate or otherwise contact the tissue. This reduces concern for sterilization of the electrical components associated with the treatment device.
- the central needle is a cannula 34 and the most proximal part of the block comprises a collar for attaching the assembly block 142 to a syringe barrel 44 in the same way that a regular cannula might be attached, such as a Luer lock fitting.
- the assembly block 142 is attached to the syringe body.
- the electrical connections between the driving unit 82 (not shown in Figs. 6-8) are made with the needles and the injection is accomplished.
- a conventional syringe is received in a carrier
- the syringe 32 is received in the carrier 66, for example being snap fit into the carrier, at a position at which the electrical connections are made by contact or can readily be made by making necessary connections.
- the respective electrical conductors can be gathered commonly into a cable 152, for example emerging from carrier 66 at a proximal end finger tab as shown in Figs 6 and 8. In Fig. 8, separate conductors emerge.
- the opposite finger tab can contain a manually operable triggering switch pushbutton 154 whereby the operator can enable or trigger operation of the electrical drive signal from drive unit 82 when ready, i.e., after the injection has proceeded to a predetermined point.
- the carrier 66 can have transparencies over an arrangement of a light source 112 and photodetector 114 as discussed with reference to Fig. 3 above, or other automatic means for triggering the signal, or perhaps to operate a warning or to trigger application of the signal in conjunction with other required inputs.
- the needles can be pressed to penetrate the tissue up to the full depth of the needles.
- the needles need not be of identical length; however assuming distal discharge of a central cannula 34, the voltage gradient and resulting electrical stimulation may be most effective if applied using outer electrodes 36 that are somewhat longer than the cannula.
- the length can be such that the likely volume of the treatment site to which the injected composition expands immediately before and during application of the electrical stimulation voltage gradient, preferably without substantially exceeding the length of the electrodes 36.
- the voltage gradient can be applied between the outer electrodes (i.e., not using the cannula as an electrode) or between either and/or both of the outer electrodes and the cannula in an alternating or other timed manner.
- a contact end plate in the form of a cylindrical pad 162 having a central opening through which the cannula protrudes, forming one of the two electrodes.
- the contact end plate forms the other electrode.
- the end plate can be axially displaceable against resilient pressure from a spring (not shown).
- the end plate can comprise a flexible cover on a resilient body that is compressed during an injection. In any event, the contact plate bears against the surface of the tissue and provides one point of electrical contact.
- Fig. 9 shows an alternative embodiment in which a substantially conventional syringe body has a cannula and two spaced parallel electrode needles 36 on either side of the cannula.
- the cannula and the electrodes make electrical contact with a small circuit card 172 that serves to establish electrical connections and also can provide the mechanical mounting for the needles 36.
- the circuit card 172 can have conductive lands that are soldered to the needles or can have spring clips that engage the needles (not shown).
- the leads for the driving unit (not shown in Fig. 9) can be permanently terminated at the circuit card, e.g., by soldering, or can be attached to contact points on the card using spring contact clips or plug and receptacle connections.
- Figs. 10 and 11 illustrate variations on the carrier arrangement of Figs. 6-8.
- the cannula 34 is one electrode and the opposed electrode comprises an annular contact plate 162 similar to that of Fig. 8, but bearing against the tissue under the resilient pressure of a helical spring 182.
- a similar arrangement has resiliently collapsible plastic arms 192 forming an enclosure with angled sides. As the device is used to make an injection, the distal side contacts the tissue and resiliently compresses the enclosure. This collapses the enclosure over a distance determined by the depth of the injection, while keeping resilient pressure between the distal side of the contact plate and the tissue.
- Fig. 10 and 11 illustrate variations on the carrier arrangement of Figs. 6-8.
- the cannula 34 is one electrode and the opposed electrode comprises an annular contact plate 162 similar to that of Fig. 8, but bearing against the tissue under the resilient pressure of a helical spring 182.
- a similar arrangement has resiliently collapsible plastic arms 192 forming an enclosure with angled sides
- FIG. 12 illustrates an example of a hybrid arrangement in which a conventional syringe such as a disposable plastic syringe 32 is snap-fit into a carrier 66 that comprises a light source and photodetector trigger generating circuit 112 as in Fig. 3, a spring like contactor as in Fig. 4 and a spring contact 193 for making electrical connection with the cannula 34.
- a connection cable 152 Preferably the syringe 32 snaps into the carrier at a predetermined position defined by the respective structures.
- the carrier 66 has been coupled to an external electrical drive unit 82.
- a carrier as shown in Figs. 6, 8, 11 , 12, etc. can comprise a battery compartment and a compact circuit (not shown) to provide the driving signal for the electrodes.
- the driving signal may be a specific signal that is optimized for a given therapeutic treatment, which can be identified by appropriate labels, color coding or other identification of the carrier.
- the carrier can be supplied with pre-loaded syringes containing the required composition for the treatment for which the carrier's drive unit signal is adapted.
- Fig. 2 it is possible to employ electrodes that are electrically insulated by surface insulation 104 over a part of their length, so that the electric field gradient occurs substantially at the depth of an injected composition.
- Figs. 13 and 14 apply a similar structural arrangement to an embodiment in which a surface electrode 136 forms one electrode, and a cannula bearing an insulating layer 104 forms the other electrode.
- the cannula comprises a conductive material such as stainless steel, but is insulated over a proximal portion of its length and thus makes electrical contact with tissue 50 only at the exposed conductive distal end portion 105 of the cannula.
- the electric field gradient and resulting current are disposed between the distal end and the surface electrode 136, extending substantially axially.
- the injected composition at least initially will occupy a volume that generally surrounds the point of the cannula.
- not all of the injected composition will be along a line between the surface electrode 136 and the conductive end 105 of the cannula. Insulating the proximal part of the cannula improves that application of the electric field to the part of the tissue where the composition is injected, but does not ensure that the field and the composition wholly coincide.
- an injection can be made to a given depth, followed by application of an electrical field at a corresponding depth, for example including insertion of an electrode or array of two or more electrodes after the injection, so as to provide a field that intersects at least some and preferably most of the tissue volume where the injected composition resides.
- Fig. 14 shows an alternative embodiment in which a surface electrode 136 is used in opposition to an electrode/cannula 34 on opposite sides of tissue 50, for example on opposite sides of a patient's limb.
- the surface electrode 136 occupies most of the circumference of the limb and the injection is made to discharge at a depth, followed by electrical stimulation between the electrode/cannula at depth as generally surrounded by the surface electrode at the skin surface.
- Figs. 16-20 illustrate a number of array variations involving two or more electrodes or arrangements in which there are two or more electrodes of which optionally at least one, and potentially more than one, is a cannula having at least a portion that is conductive and is coupleable to a drive signal.
- the cannula is shown in broken lines to indicate that the cannula can remain in place, for example being used as a electrode, or can be removable after making an injection, with other electrodes 36 being arranged to provide an electric field in the area of the injection.
- Fig. 16 shows that the cannula (assuming that it is left in place during electrical stimulation) can be inert or powered. The polarities of the respective parts can be reversed and the signal can involve a potential difference between the electrodes or between the cannula and the electrodes, or between the cannula and either of the electrodes.
- the cannula can be employed with an array of three electrodes (Fig. 17) or four electrodes (Fig. 18) or more.
- the electrodes surround a centered cannula and can apply a field by connecting an electric potential in opposition to the cannula or in opposition to one or more of the other electrodes. In either case the effect is to apply a voltage gradient and to produce a current flow through the tissue in at least a part of the tissue that is exposed to the injected composition.
- the cannula and one or more electrodes are opposed conductors that apply the electrical energy.
- a plurality of opposed electrodes are placed at substantially equal distances from the cannula.
- the electrodes and the cannula, or pairs or electrodes function as a straddling pair, a triangle, a square, a pentagon, and a hexagon array of conductors.
- Fig. 19 shows a two cannula arrangement in which the cannulae function as electrical connections and also inject the composition.
- each cannula is provided with one or more lateral openings, for example opening toward a space between the cannulae.
- the composition 52 is thus discharged at least substantially into the tissue area between the electrodes (cannulae).
- Fig. 20 shows an array in which one cannula 34 injects between two piercing electrodes.
- the cannula which in this case discharges at its end, is shorter than the electrodes or at least is less deeply embedded in the tissue. As a result the field encompasses the area of the injected composition in an efficient manner.
- the electrical stimulation treatment technique of the invention exposes the medical technician to some of the same dangers as occur with injections generally, such as exposure to potentially infected bodily fluids, and in particular exposure to possible infection introduced by inadvertent needle sticks.
- the invention may employ piercing electrodes in addition to piercing cannulae, the danger of sharps injuries is multiplied. According to the invention, such dangers are minimized in several ways. As discussed, for example, with reference to Figs. 4 and 5, one of the electrodes can be a surface contact member and the other can be the cannula itself, which reduces the number of sharp points involved.
- the sharp portions of the device are made retractable into a protective sheath to prevent pricks.
- a deployable sheath extends to encompass the length of a cannula or electrode to prevent inadvertent contact with the sharp end.
- the deployment and retraction of the respective protective or dangerously sharp structures, respectively are automated or timed in conjunction with the injection and the electrical stimulation steps.
- US Patents 6,015,438 and 5,989,220 - both to Shaw teach structures whereby a sharp cannula can be engaged by a syringe plunger at the end of an injection stroke or a needle can be engaged when a sleeve cannula is pulled free, the engaged needle being retracted automatically into the syringe or cannula barrel by an axially directed helical spring.
- the present invention can employ a similar spring retraction structure.
- both the injection cannula and any piercing electrodes are arranged to retract, and this can be accomplished by a spring biasing arrangement as in Shaw.
- a spring biasing arrangement as in Shaw.
- Similar arrangements for engaging and retracting needles into a safe and retracted position are disclosed in US Patent 6,156,013 - Mahurkar; 6,090,077 - Shaw; 6,096,005 - Botich et al.; 6,099,500 - Dysarz; 6,117,113 - Novacek et al.; and 6,117,107 - Chen.
- the electrical drive unit 82 can be triggered by a signal developed optoelectrically (or otherwise) when the plunger of a syringe reaches a particular point of advance.
- the drive unit can be arranged to produce a signal at the conclusion of electrical stimulation that causes retraction of the cannula and/or the electrodes, or deploys a protective sheath.
- the cannula or electrode can be biased toward retraction by a compressed helical spring, for example as in Shaw '438, and held in an advanced position against spring pressure, in part by a fusible link structure coupled in a circuit with the drive unit.
- the fusible link is normally strong enough to provide a structural hold to keep the cannula or electrode in the advanced position against pressure of the compressed spring.
- the drive unit couples a sufficient electrical current to the fusible link to melt the link, thus breaking the structural hold.
- the spring then retracts the cannula or elongated electrode into the body of the electrical stimulation device.
- FIGs. 21-27 illustrate a number of practical applications of the invention, including particular structures for use with popular inexpensive syringes, particular carriers for such syringes, robust and dependable techniques for obtaining good electrical connections, and associated sensing devices whereby application of electrical energy can be triggered by a signal generated when the injection of the therapeutic agent reaches a predetermined point in its progress.
- Figs. 21-23 illustrate alternative syringe tube/cannula/electrode assemblies. These embodiments comprise carriers and syringes, which can by supplied individually in separate sterile packages, or as an optionally pre- assembled kit. Preferably the syringes used are conventional low cost disposables. It is also possible to employ a specially structured syringe, such as one in which portions of the cannula have electrically insulating surfaces. [0112] In the embodiments shown in Figs. 21-23, the cannula 34 of the syringe 32 functions as at least one of the electrodes.
- the devices comprise one or more suitable syringes 32 with attached cannulae 34, and means for making electrical contact as described above, preferably including structure for physically attaching the respective parts together securely, such as a snap-together arrangement.
- Figs. 21 and 22 show plural-syringe arrays .
- a standard 1cc tuberculin syringe 32 with an attached needle/electrode (i.e., cannula) 34 is mechanically snapped into a molded plastic holder 202.
- the holder fixes the position of the syringe and cannula during the injection, without interfering substantially with handling of the syringe barrel and plunger.
- the holder 202 also ensures electrical contact with the needle/electrode, preferably by use of one or more spring loaded metal contacts 203 for each needle.
- the spring contact 203 can be attached to electrical leads, or can be electrically connected to a convenient pin or plug contact (not shown) located clear of the needle and the plunger.
- two standard syringes 32 are received in respective complementary depressions or channels in a single molded plastic carrier 202, each channel having an electrical contact structure engaging against the cannula or needle.
- the two syringes can be used simultaneously to inject the same or different components, and for this purpose it is possible to operate the plungers together (via an optional clip - not shown - for attaching the plungers to move as one) or separately, e.g., one after the other in a sequence or timing technique that also involves timing of the application of electrical energy.
- Fig. 22 illustrates an alternative in which each of the syringes has its own discrete carrier 204. However the carriers 204 are attachable to one another by snap fitting pins and receptacles, shown schematically. [0116] As also shown in Fig. 22, it is possible to divert the needle or cannula parts of standard syringes to adjust the spacing between two needles used as electrodes, at least one also being used as the injection cannula.
- the syringes can be specially manufactured with such a diversion or Z-bend 207 in the needle, allowing the needle to be closer to an adjacent needle that would otherwise be permitted if one or both of the respective needles was wholly straight and aligned to the longitudinal center axis of the syringe.
- a syringe manufactured specifically for use as shown it is also advantageous to supply the syringe and carrier in a sterile assembly with the syringe pre-filled, volume adjusted and air-evacuated, etc.
- the technician can fill the syringe in a conventional way from a standard stoppered vial.
- the electrical leads are coupled to a source for generating the electrical signal as discussed above (not shown in Figs. 21-23).
- the embodiments shown are such that the electrical conductors can be placed so as to prevent or inadvertent shock by contact with conductors apart from the needle electrodes themselves.
- Fig. 22 illustrates another arrangement wherein a carrier 208 receives a snap-mounted standard syringe and has a second electrode 36 that is not a syringe cannula.
- the carrier electrode 36 can be a solid sharpened wire of suitable strength.
- the syringe cannula 34 can have a Z-bend 207 as shown to adjust the spacing between the electrodes.
- a Z-bend can be provided exclusively in the solid wire electrode of the carrier, which is shown as straight in the example of Fig. 23. It is preferable that only one of the electrodes be diverted if necessary to adjust the electrode spacing, and making the solid wire the diverted electrode, rather than using a Z-bend syringe, permits use of an unmodified standard syringe and cannula.
- the electrical connection to the solid wire electrode can be made through a conductor molded into the carrier.
- the electrical connection to the syringe cannula is made through a metal spring clip 203 that clips over the cannula.
- the barrel of the syringe can snap resiliently between molded channel walls 209 as shown.
- Fig. 24 shows an alternative embodiment that can be used with an unmodified standard syringe (not shown in Fig. 24).
- the carrier 212 in this case is formed by an integrally molded plastic channel member that has two solid wires extending through the molded material of the side walls to emerge as sharpened protruding electrodes 36.
- the channel member carrier 212 is dimensioned to snap around a standard syringe (not shown), the cannula of which syringe is to be straddled by the electrodes 36 molded into the walls of the channel member 212.
- the channel member is structured at the end opposite from the electrodes to engage with the upper end of the syringe barrel, having lateral openings 213 into which the usual finger tabs at the end of the barrel can be fitted.
- a longitudinal gap 215 provides clearance for the plunger of the syringe.
- FIG. 25 A preferred manner for coupling electrical signals to the device of Fig. 24 is shown in Fig. 25.
- the electrode wires are exposed at two gaps 217 in the walls of the channel member.
- a connecting clip device 220 shown in Fig. 25 (in a larger scale than Fig. 24), engages with the electrode wires at the gaps 217 in the channel member carrier 212.
- the connecting clip 220 acts for securing the syringe barrel in the carrier 212, making electrical connections with the electrodes, and preferably also carrying a sensor to detect the injection status of the syringe plunger.
- the clip device 220 has four electrical contacts 222, namely two contacts on each leg part 224 as shown.
- the leg parts 224 are coupled by a bridging part 225 at a midpoint along the leg parts and operate to clasp resiliently onto the electrode wires like a clothespin. By pressing together the upper ends of the legs 224, the lower ends are resiliently moved apart and when released on the contacts 222 clamp resiliently against the electrodes at the gap 217 to obtain good electrical contact.
- Two spaced electrical contacts 222 are provided on each leg.
- Two coupled contacts on each leg could be provided for simple redundancy to ensure that the signal generating device is properly connected.
- two separate contacts are provided on each leg, coupled through their contact with the electrode.
- the control unit discussed above
- the doubled contacts 222 can also independently verify that the electrical signal is properly coupled to the patient's tissues, namely by monitoring both the current in the lines and the voltage across the lines. This arrangement ensures electrical connection and application of the required electric field.
- the bridging part 225 of the connecting clip 220 carries a proximity sensor 227 that produces a signal developed as a function of passage of the syringe plunger at least to a predetermined point along an injection stroke.
- the point can be full injection or partial.
- Various specific kinds of sensors can be used to produce a signal based on electromagnetic, optical or sonic variations, etc.
- the sensor can respond to a magnetic or reflective material on the plunger.
- the sensor can produce an analog level, a contact closure or a switched edge from a semiconductor switch element.
- Figs. 26 and 27 illustrate an alternative embodiment. As shown in Fig. 26, two (or more) electrodes 36 are spaced from one another and span an opening 233 in a molded plastic element 230, shown generally, for holding a syringe (not shown). A connector 234 as shown in Fig. 27 is inserted and turned by 90 degrees, such that two conductor posts 222 are pressed against each of the electrodes 36. In other respects, the connections can be handled as discussed above.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/504,830 US20050154434A1 (en) | 2002-03-07 | 2003-03-06 | Clinical syringe with electrical stimulation aspects |
CA002477872A CA2477872A1 (en) | 2002-03-07 | 2003-03-06 | Clinical syringe with electrical stimulation aspects |
AU2003230601A AU2003230601A1 (en) | 2002-03-07 | 2003-03-06 | Clinical syringe with electrical stimulation aspects |
JP2003574246A JP2005518904A (en) | 2002-03-07 | 2003-03-06 | Clinical syringe with electrical stimulation aspect |
EP03723686A EP1480692A2 (en) | 2002-03-07 | 2003-03-06 | Clinical syringe with electrical stimulation aspects |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36253302P | 2002-03-07 | 2002-03-07 | |
US60/362,533 | 2002-03-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003075978A2 true WO2003075978A2 (en) | 2003-09-18 |
WO2003075978A3 WO2003075978A3 (en) | 2003-12-24 |
Family
ID=27805187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/006852 WO2003075978A2 (en) | 2002-03-07 | 2003-03-06 | Clinical syringe with electrical stimulation aspects |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050154434A1 (en) |
EP (1) | EP1480692A2 (en) |
JP (1) | JP2005518904A (en) |
AU (1) | AU2003230601A1 (en) |
CA (1) | CA2477872A1 (en) |
WO (1) | WO2003075978A2 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2893256A1 (en) * | 2005-11-14 | 2007-05-18 | Yves Scherman | GENERATOR OF ELECTRIC PULSES UNIPOLAR. |
JP2008501404A (en) * | 2004-06-02 | 2008-01-24 | カール フレデリック エドゥマン | Use of electric fields to minimize rejection to implanted devices and materials |
JP2008503292A (en) * | 2004-06-24 | 2008-02-07 | スフェルゲン | Devices that move molecules to cells using electrical force |
JP2009525829A (en) * | 2006-02-11 | 2009-07-16 | ジェネトロニクス,インコーポレイティド | Apparatus and method for single needle in vivo electroporation |
CN101804224A (en) * | 2010-04-06 | 2010-08-18 | 陈丽晔 | Medical instrument-combined electric pulse introduction device |
US8834428B2 (en) | 2007-08-14 | 2014-09-16 | Fred Hutchinson Cancer Research Center | Needle array assembly and method for delivering therapeutic agents |
US8998842B2 (en) | 2006-01-31 | 2015-04-07 | Ares Trading S.A. | Injection device with a capacitive proximity sensor |
EP3067079A1 (en) * | 2015-03-13 | 2016-09-14 | Henke-Sass, Wolf GmbH | Syringe with a first and a second syringe barrel |
WO2018034784A1 (en) * | 2016-08-17 | 2018-02-22 | Amgen Inc. | Drug delivery device with placement detection |
US10478157B2 (en) | 2011-10-28 | 2019-11-19 | Presage Biosciences, Inc. | Methods for drug delivery |
US10575897B2 (en) | 2004-04-01 | 2020-03-03 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
US11007365B2 (en) | 2006-03-03 | 2021-05-18 | Oncosec Medical Incorporated | Method and device for treating microscopic residual tumors remaining in tissues following surgical resection |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6912417B1 (en) | 2002-04-05 | 2005-06-28 | Ichor Medical Systmes, Inc. | Method and apparatus for delivery of therapeutic agents |
US7351246B2 (en) * | 2004-01-20 | 2008-04-01 | Epley John M | Minimally invasive, sustained, intra-tympanic drug delivery system |
US7647112B2 (en) * | 2004-02-11 | 2010-01-12 | Ethicon, Inc. | System and method for selectively stimulating different body parts |
ES2695235T3 (en) | 2004-03-08 | 2019-01-02 | Ichor Medical Systems Inc | Improved apparatus for the delivery, electrically mediated, of therapeutic agents |
US20070167903A1 (en) * | 2004-06-11 | 2007-07-19 | University Of South Florida | Nervous Tissue Electrode Device |
US20070244425A1 (en) * | 2006-03-29 | 2007-10-18 | Pond Gary J | Irrigation and aspiration handpiece device |
US9895494B2 (en) * | 2007-01-25 | 2018-02-20 | DePuy Synthes Products, Inc. | Syringe with energy delivery component and method of use |
MX2009009999A (en) * | 2007-03-19 | 2010-03-17 | Insuline Medical Ltd | Method and device for drug delivery. |
EP4328297A2 (en) * | 2008-01-17 | 2024-02-28 | Inovio Pharmaceuticals, Inc. | Variable current density single needle electroporation system and method |
US20100249488A1 (en) * | 2009-03-30 | 2010-09-30 | MagneGene, Inc. | Method of contactless magnetic electroporation |
US9770560B2 (en) * | 2009-11-12 | 2017-09-26 | Pourang Bral | Means and method to administer injections with little or no pain |
CN103717249B (en) * | 2011-06-15 | 2017-03-22 | 克洛恩泰克制药股份公司 | Injection needle and device |
KR101310716B1 (en) * | 2011-08-26 | 2013-10-14 | (주)아모레퍼시픽 | Aesthetic apparatus using high-frequency treatment |
US9433725B2 (en) | 2011-12-23 | 2016-09-06 | Alcon Research, Ltd. | Combined coaxial and bimanual irrigation/aspiration apparatus |
ES2482612B1 (en) * | 2012-10-25 | 2015-05-11 | Universitat Pompeu Fabra | System for the prevention of bacterial infections in needle paths |
EP2986331B1 (en) | 2013-06-06 | 2018-10-24 | Novartis AG | Transformer irrigation/aspiration device |
EP3060276B1 (en) | 2013-10-24 | 2023-05-24 | Trustees of Boston University | Infusion system for preventing mischanneling of multiple medicaments |
US9782325B1 (en) * | 2014-06-13 | 2017-10-10 | Physio Partners, Llc | Needle systems for dry needling |
KR101525854B1 (en) * | 2015-02-06 | 2015-06-11 | (주)엠큐어 | Portable Auto Inejector |
JP7125204B2 (en) | 2015-07-08 | 2022-08-24 | トラスティーズ オブ ボストン ユニバーシティ | Infusion system and its components |
RU2746466C2 (en) | 2015-12-30 | 2021-04-14 | Иновио Фармасьютикалз, Инк. | Electroporation device with removable needle head with locking system in retracted position |
WO2017145689A1 (en) * | 2016-02-22 | 2017-08-31 | 公益財団法人東京都医学総合研究所 | Electrodes for electroporation |
JP6910075B2 (en) | 2016-03-28 | 2021-07-28 | イコル メディカル システムズ,インク. | Methods and devices for delivery of therapeutic agents |
DE102016110379A1 (en) * | 2016-06-06 | 2017-12-07 | Pajunk GmbH Medizintechnologie | Unipolar cannula |
AU2017376132A1 (en) * | 2016-12-12 | 2019-07-11 | Neuronoff, Inc. | Electrode curable and moldable to contours of a target in bodily tissue and methods of manufacturing and placement and dispensers therefor |
EP3565516A4 (en) * | 2017-01-06 | 2020-07-01 | Trustees of Boston University | Infusion system and components thereof |
US11511037B2 (en) * | 2018-06-08 | 2022-11-29 | Analog Devices, Inc. | Systems and methods for measuring needle depth |
MX2022000668A (en) | 2019-07-16 | 2022-05-20 | Beta Bionics Inc | Ambulatory device and components thereof. |
US20220399096A1 (en) * | 2019-11-07 | 2022-12-15 | Haniva Llc | Method and apparatus for administering a cancer drug |
US11278661B2 (en) | 2020-03-10 | 2022-03-22 | Beta Bionics, Inc. | Infusion system and components thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5676646A (en) | 1992-04-08 | 1997-10-14 | Genetronics, Inc. | Flow through electroporation apparatus |
US5702359A (en) | 1995-06-06 | 1997-12-30 | Genetronics, Inc. | Needle electrodes for mediated delivery of drugs and genes |
US5704908A (en) | 1996-10-10 | 1998-01-06 | Genetronics, Inc. | Electroporation and iontophoresis catheter with porous balloon |
US5810762A (en) | 1995-04-10 | 1998-09-22 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
WO1999001157A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
WO1999001158A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
WO1999001175A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo |
US6110161A (en) | 1997-04-03 | 2000-08-29 | Electrofect As | Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4269174A (en) * | 1979-08-06 | 1981-05-26 | Medical Dynamics, Inc. | Transcutaneous vasectomy apparatus and method |
US6241701B1 (en) * | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
-
2003
- 2003-03-06 AU AU2003230601A patent/AU2003230601A1/en not_active Abandoned
- 2003-03-06 JP JP2003574246A patent/JP2005518904A/en active Pending
- 2003-03-06 WO PCT/US2003/006852 patent/WO2003075978A2/en active Application Filing
- 2003-03-06 US US10/504,830 patent/US20050154434A1/en not_active Abandoned
- 2003-03-06 CA CA002477872A patent/CA2477872A1/en not_active Abandoned
- 2003-03-06 EP EP03723686A patent/EP1480692A2/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5676646A (en) | 1992-04-08 | 1997-10-14 | Genetronics, Inc. | Flow through electroporation apparatus |
US5810762A (en) | 1995-04-10 | 1998-09-22 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
US5702359A (en) | 1995-06-06 | 1997-12-30 | Genetronics, Inc. | Needle electrodes for mediated delivery of drugs and genes |
US5704908A (en) | 1996-10-10 | 1998-01-06 | Genetronics, Inc. | Electroporation and iontophoresis catheter with porous balloon |
US6110161A (en) | 1997-04-03 | 2000-08-29 | Electrofect As | Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
WO1999001157A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
WO1999001158A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
WO1999001175A1 (en) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10575897B2 (en) | 2004-04-01 | 2020-03-03 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
JP4856633B2 (en) * | 2004-06-02 | 2012-01-18 | カール フレデリック エドゥマン | Device for applying an electric field to minimize rejection to implanted devices and materials |
JP2008501404A (en) * | 2004-06-02 | 2008-01-24 | カール フレデリック エドゥマン | Use of electric fields to minimize rejection to implanted devices and materials |
JP2015163230A (en) * | 2004-06-24 | 2015-09-10 | スフェルゲン | Device for moving molecule to cell by using electric force |
JP2008503292A (en) * | 2004-06-24 | 2008-02-07 | スフェルゲン | Devices that move molecules to cells using electrical force |
JP2012250044A (en) * | 2004-06-24 | 2012-12-20 | Sphergen | Device transferring molecule to cell by use of electric force |
FR2893256A1 (en) * | 2005-11-14 | 2007-05-18 | Yves Scherman | GENERATOR OF ELECTRIC PULSES UNIPOLAR. |
WO2007059162A2 (en) * | 2005-11-14 | 2007-05-24 | Sphergen | Unipolar electric pulse generator |
WO2007059162A3 (en) * | 2005-11-14 | 2008-11-06 | Sphergen | Unipolar electric pulse generator |
US8998842B2 (en) | 2006-01-31 | 2015-04-07 | Ares Trading S.A. | Injection device with a capacitive proximity sensor |
US10130763B2 (en) | 2006-01-31 | 2018-11-20 | Ares Trading S.A. | Injection device with a capacitive proximity sensor |
US11331479B2 (en) | 2006-02-11 | 2022-05-17 | Inovio Pharmaceuticals, Inc. | Device and method for single-needle in vivo electroporation |
JP2009525829A (en) * | 2006-02-11 | 2009-07-16 | ジェネトロニクス,インコーポレイティド | Apparatus and method for single needle in vivo electroporation |
US10369359B2 (en) | 2006-02-11 | 2019-08-06 | Genetronics, Inc. | Device and method for single-needle in vivo electroporation |
US11007365B2 (en) | 2006-03-03 | 2021-05-18 | Oncosec Medical Incorporated | Method and device for treating microscopic residual tumors remaining in tissues following surgical resection |
US8926567B2 (en) | 2007-08-14 | 2015-01-06 | Fred Hutchinson Cancer Research Center | Needle array assembly and method for delivering therapeutic agents |
US9205201B2 (en) | 2007-08-14 | 2015-12-08 | Fred Hutchinson Cancer Research Center | Needle array assembly and method for delivering therapeutic agents |
US9205202B2 (en) | 2007-08-14 | 2015-12-08 | Fred Hutchinson Cancer Research Center | Needle array assembly and method for delivering therapeutic agents |
US8834428B2 (en) | 2007-08-14 | 2014-09-16 | Fred Hutchinson Cancer Research Center | Needle array assembly and method for delivering therapeutic agents |
CN101804224A (en) * | 2010-04-06 | 2010-08-18 | 陈丽晔 | Medical instrument-combined electric pulse introduction device |
US10478157B2 (en) | 2011-10-28 | 2019-11-19 | Presage Biosciences, Inc. | Methods for drug delivery |
US10238802B2 (en) | 2015-03-13 | 2019-03-26 | Henke-Sass, Wolf Gmbh | Syringe with a first and a second syringe barrel |
EP3067079A1 (en) * | 2015-03-13 | 2016-09-14 | Henke-Sass, Wolf GmbH | Syringe with a first and a second syringe barrel |
WO2018034784A1 (en) * | 2016-08-17 | 2018-02-22 | Amgen Inc. | Drug delivery device with placement detection |
Also Published As
Publication number | Publication date |
---|---|
CA2477872A1 (en) | 2003-09-18 |
US20050154434A1 (en) | 2005-07-14 |
EP1480692A2 (en) | 2004-12-01 |
JP2005518904A (en) | 2005-06-30 |
AU2003230601A1 (en) | 2003-09-22 |
WO2003075978A3 (en) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050154434A1 (en) | Clinical syringe with electrical stimulation aspects | |
US10589088B2 (en) | Apparatus for application of a pulsed radio frequency therapy in a vascular system or another cavity or tissue of the human or animal body | |
AU2007215263B2 (en) | Device and method for single-needle in vivo electroporation | |
US5702359A (en) | Needle electrodes for mediated delivery of drugs and genes | |
US6912417B1 (en) | Method and apparatus for delivery of therapeutic agents | |
US8455228B2 (en) | Method to facilitate directed delivery and electroporation using a charged stream | |
ES2312479T3 (en) | NEUROSTIMULATOR NEEDLE NEEDLE GUIDE SYSTEM. | |
US20080058706A1 (en) | Modular electroporation device with disposable electrode and drug delivery components | |
US20070156082A1 (en) | Device for transferring molecules to cells using an electric force | |
IL33519A (en) | Combined electrode and hypodermic syringe needle | |
US20060036210A1 (en) | Modular electroporation device with disposable electrode and drug delivery components | |
KR19980702609A (en) | Electroduction System for Clinical Applications with Voltage Control Feedback | |
JP2009525829A5 (en) | ||
KR20170047300A (en) | Selective nerve fiber block method and system | |
US20100191174A1 (en) | Hand-held electrical stimulation device | |
US20050149145A1 (en) | Enhanced device for diminishing or eliminating the pain caused by superficial therapeutic injection or superficial body tissue sampling or the pain from a superficial injury as well as for the reduction of hemorrhage from an injured area | |
BRPI0618588A2 (en) | unipolar electric pulse generator | |
JP2018511449A (en) | Collagen stimulation apparatus and method | |
US20140378940A1 (en) | Anti-nociceptive apparatus | |
RU157751U1 (en) | DEVICE FOR TRANSDERMAL ELECTROPHARMOSTIMULATION | |
MX2008008981A (en) | Device and method for single-needle in vivo electroporation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003230601 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003574246 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2477872 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003723686 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003723686 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10504830 Country of ref document: US |